Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sarkar, Sohinee ^a   Ulett, Glen C ^b   Totsika, Makrina ^a   Phan, Minh Duy ^a   Schembri, Mark A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KANAMYCIN; O ANTIGEN; O1 ANTIGEN; O18 ANTIGEN; O6 ANTIGEN; POLYSACCHARIDE; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC COMPLEMENTATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; SEROTYPE; SURVIVAL; URINARY TRACT; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; BACTERIAL CAPSULE; ESCHERICHIA COLI INFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; ESCHERICHIA COLI INFECTIONS; MICE; O ANTIGENS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84899527395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094786     Document Type: Article

References (98)

1. Stamm WE, Norrby SR (2001) Urinary tract infections: disease panorama and challenges. J Infect Dis 183 Suppl 1: S1-4. (Pubitemid 32174135)
2. Foxman B (2002) Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. American Journal of Medicine 113: 5S-13S.
3. Chenoweth CE, Saint S (2011) Urinary tract infections. Infect Dis Clin North Am 25: 103-115.
4. Buonsenso D, Cataldi L (2012) Urinary tract infections in children: a review. Minerva Pediatr 64: 145-157.
5. Nicolle LE (2001) Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol 22: 167-175.
6. Stamm WE, Hooton TM (1993) Management of Urinary-Tract Infections in Adults. New England Journal of Medicine 329: 1328-1334.
7. Hacker J, Bender L, Ott M, Wingender J, Lund B, et al. (1990) Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog 8: 213-225. (Pubitemid 20291562)
8. Oelschlaeger TA, Dobrindt U, Hacker J (2002) Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int J Antimicrob Agents 19: 517-521. (Pubitemid 34831657)
9. Klemm P, Schembri MA (2000) Bacterial adhesins: function and structure. International Journal of Medical Microbiology 290: 27-35. (Pubitemid 30217988)
10. Oelschlaeger TA, Dobrindt U, Hacker J (2002) Virulence factors of uropathogens. Curr Opin Urol 12: 33-38. (Pubitemid 34033066)
11. Garcia EC, Brumbaugh AR, Mobley HL (2011) Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun 79: 1225-1235.
12. Johnson JR (1991) Virulence Factors in Escherichia coli Urinary Tract Infection. Clin Microbiol Rev 4: 80-128.
13. Bahrani-Mougeot FK, Buckles EL, Lockatell CV, Hebel JR, Johnson DE, et al. (2002) Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 45: 1079-1093. (Pubitemid 35007450)
14. Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ (2009) A Live-Attenuated Vaccine for the Treatment of Urinary Tract Infection by Uropathogenic Escherichia coli. Journal of Infectious Diseases 200: 263-272.
15. Burns SM, Hull SI (1999) Loss of resistance to ingestion and phagocytic killing by O(-) and K(-) mutants of a uropathogenic Escherichia coli O75:K5 strain. Infect Immun 67: 3757-3762. (Pubitemid 29356988)
16. Burns SM, Hull SI (1998) Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect Immun 66: 4244-4253.
17. Tomas JM, Ciurana B, Benedi VJ, Juarez A (1988) Role of Lipopolysaccharide and Complement in Susceptibility of Escherichia-Coli and Salmonella-Typhimurium to Non-Immune Serum. Journal of General Microbiology 134: 1009-1016.
18. Stenutz R, Weintraub A, Widmalm G (2006) The structures of Escherichia coli O-polysaccharide antigens. Fems Microbiology Reviews 30: 382-403.
19. Orskov I, Orskov F, Jann B, Jann K (1977) Serology, Chemistry, and Genetics of O and K Antigens of Escherichia-Coli. Bacteriological Reviews 41: 667-710. (Pubitemid 8194910)
20. Totsika M, Moriel DG, Idris A, Rogers BA, Wurpel DJ, et al. (2012) Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug Targets 13: 1386-1399.
21. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700. (Pubitemid 34800232)
22. Perez JM, McGarry MA, Marolda CL, Valvano MA (2008) Functional analysis of the large periplasmic loop of the Escherichia coli K-12 WaaL O-antigen ligase. Mol Microbiol 70: 1424-1440.
23. Heinrichs DE, Monteiro MA, Perry MB, Whitfield C (1998) The assembly system for the lipopolysaccharide R2 core-type of Escherichia coli is a hybrid of those found in Escherichia coli K-12 and Salmonella enterica - Structure and function of the R2 WaaK and WaaL homologs. Journal of Biological Chemistry 273: 8849-8859. (Pubitemid 28176166)
24. Whitfield C, Roberts IS (1999) Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol 31: 1307-1319. (Pubitemid 29110091)
25. Roberts IS (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annual Review of Microbiology 50: 285-315.
26. Weiss J, Victor M, Cross AS, Elsbach P (1982) Sensitivity of K1-Encapsulated Escherichia-Coli to Killing by the Bactericidal Permeability-Increasing Protein of Rabbit and Human-Neutrophils. Infect Immun 38: 1149-1153. (Pubitemid 13206266)
27. Howard CJ, Glynn AA (1971) Virulence for mice of strains of Escherichia coli related to effects of K antigens on their resistance to phagocytosis and killing by complement. Immunology 20: 767-&.
28. Leying H, Suerbaum S, Kroll HP, Stahl D, Opferkuch W (1990) The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infect Immun 58: 222-227. (Pubitemid 20064888)
29. Kim KS, Itabashi H, Gemski P, Sadoff J, Warren RL, et al. (1992) The K1-Capsule Is the Critical Determinant in the Development of Escherichia-Coli Meningitis in the Rat. Journal of Clinical Investigation 90: 897-905.
30. Bjorksten B, Bortolussi R, Gothefors L, Quie PG (1976) Interaction of E. coli strains with human serum: lack of relationship to K1 antigen. J Pediatr 89: 892-897. (Pubitemid 8029084)
31. Buckles EL, Wang XL, Lane MC, Lockatell CV, Johnson DE, et al. (2009) Role of the K2 Capsule in Escherichia coli Urinary Tract Infection and Serum Resistance. Journal of Infectious Diseases 199: 1689-1697.
32. Stawski G, Nielsen L, Orskov F, Orskov I (1990) Serum sensitivity of a diversity of Escherichia coli antigenic reference strains. Correlation with an LPS variation phenomenon. Apmis 98: 828-838. (Pubitemid 20335494)
33. Silver RP, Vann WF, Aaronson W (1984) Genetic and molecular analyses of Escherichia coli K1 antigen genes. J Bacteriol 157: 568-575. (Pubitemid 14190945)
34. Silver RP, Aaronson W, Vann WF (1987) Translocation of capsular polysaccharides in pathogenic strains of Escherichia coli requires a 60-kilodalton periplasmic protein. J Bacteriol 169: 5489-5495. (Pubitemid 18017842)
35. Wunder DE, Aaronson W, Hayes SF, Bliss JM, Silver RP (1994) Nucleotide sequence and mutational analysis of the gene encoding kpsD, a periplasmic protein involved in transport of polysialic acid in Escherichia coli K1. J Bacteriol 176: 4025-4033. (Pubitemid 24191287)
36. Heermann R, Zeppenfeld T, Jung K (2008) Simple generation of site-directed point mutations in the Escherichia coli chromosome using Red(R)/ET(R) Recombination. Microb Cell Fact 7: 14.
37. Lederberg J (1951) Streptomycin resistance; a genetically recessive mutation. J Bacteriol 61: 549-550.
38. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, et al. (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75: 3233-3244. (Pubitemid 47040924)
39. Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, et al. (2010) UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78: 1659-1669.
40. Duell BL, Carey AJ, Tan CK, Cui X, Webb RI, et al. (2012) Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J Immunol 188: 781-792.
41. Tan CK, Carey AJ, Cui X, Webb RI, Ipe D, et al. (2012) Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection. Infect Immun 80: 3145-3160.
42. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645. (Pubitemid 30412767)
43. Phan MD, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, et al. (2013) The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Clone. PLoS Genet 9: e1003834.
44. Mosberg JA, Gregg CJ, Lajoie MJ, Wang HH, Church GM (2012) Improving lambda red genome engineering in Escherichia coli via rational removal of endogenous nucleases. PLoS One 7: e44638.
45. Webb JS, Nikolakakis KC, Willett JL, Aoki SK, Hayes CS, et al. (2013) Delivery of CdiA nuclease toxins into target cells during contact-dependent growth inhibition. PLoS One 8: e57609.
46. Derbise A, Lesic B, Dacheux D, Ghigo JM, Carniel E (2003) A rapid and simple method for inactivating chromosomal genes in Yersinia. FEMS Immunol Med Microbiol 38: 113-116. (Pubitemid 37297836)
47. Meissner PS, Sisk WP, Berman ML (1987) Bacteriophage lambda cloning system for the construction of directional cDNA libraries. Proc Natl Acad Sci U S A 84: 4171-4175.
48. Soussy CJ, Wolfson JS, Ng EY, Hooper DC (1993) Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus. Antimicrob Agents Chemother 37: 2588-2592. (Pubitemid 23357851)
49. Watve MM, Dahanukar N, Watve MG (2010) Sociobiological control of plasmid copy number in bacteria. PLoS One 5: e9328.
50. Siegele DA, Hu JC (1997) Gene expression from plasmids containing the araBAD promoter at subsaturating inducer concentrations represents mixed populations. Proc Natl Acad Sci U S A 94: 8168-8172. (Pubitemid 27343795)
51. Battaglioli EJ, Baisa GA, Weeks AE, Schroll RA, Hryckowian AJ, et al. (2011) Isolation of generalized transducing bacteriophages for uropathogenic strains of Escherichia coli. Appl Environ Microbiol 77: 6630-6635.
52. Emmerson JR, Gally DL, Roe AJ (2006) Generation of gene deletions and gene replacements in Escherichia coli O157: H7 using a temperature sensitive allelic exchange system. Biological Procedures Online 8: 153-162. (Pubitemid 44501751)
53. Goryshin IY, Naumann TA, Apodaca J, Reznikoff WS (2003) Chromosomal deletion formation system based on Tn5 double transposition: use for making minimal genomes and essential gene analysis. Genome Res 13: 644-653. (Pubitemid 36511923)
54. Winterberg KM, Luecke J, Bruegl AS, Reznikoff WS (2005) Phenotypic screening of Escherichia coli K-12 Tn5 insertion libraries, using whole-genome oligonucleotide microarrays. Appl Environ Microbiol 71: 451-459. (Pubitemid 40116301)
55. Lambertsen L, Sternberg C, Molin S (2004) Mini-Tn7 transposons for sitespecific tagging of bacteria with fluorescent proteins. Environ Microbiol 6: 726- 732.
56. Biery MC, Stewart FJ, Stellwagen AE, Raleigh EA, Craig NL (2000) A simple in vitro Tn7-based transposition system with low target site selectivity for genome and gene analysis. Nucleic Acids Res 28: 1067-1077. (Pubitemid 30107673)
57. Bird AW, Erler A, Fu J, Heriche JK, Maresca M, et al. (2012) High-efficiency counterselection recombineering for site-directed mutagenesis in bacterial artificial chromosomes. Nat Methods 9: 103-109.
58. Schwartz JA, Brittle EE, Reynolds AE, Enquist LW, Silverstein SJ (2006) UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture. J Virol 80: 769-784. (Pubitemid 43062889)
59. White EA, Spector DH (2005) Exon 3 of the human cytomegalovirus major immediate-early region is required for efficient viral gene expression and for cellular cyclin modulation. J Virol 79: 7438-7452. (Pubitemid 40756781)
60. Tuntufye HN, Goddeeris BM (2011) Use of lambda Red-mediated recombineering and Cre/lox for generation of markerless chromosomal deletions in avian pathogenic Escherichia coli. FEMS Microbiol Lett 325: 140-147.
61. Blomfield IC, Vaughn V, Rest RF, Eisenstein BI (1991) Allelic Exchange in Escherichia-Coli Using the Bacillus-Subtilis Sacb Gene and a Temperature-Sensitive Psc101 Replicon. Molecular Microbiology 5: 1447-1457. (Pubitemid 21896171)
62. Marx CJ (2008) Development of a broad-host-range sacB-based vector for unmarked allelic exchange. BMC Res Notes 1: 1.
63. Hamilton CM, Aldea M, Washburn BK, Babitzke P, Kushner SR (1989) New method for generating deletions and gene replacements in Escherichia coli. J Bacteriol 171: 4617-4622. (Pubitemid 19209055)
64. Sandvang D (1999) Novel streptomycin and spectinomycin resistance gene as a gene cassette within a class 1 integron isolated from Escherichia coli. Antimicrob Agents Chemother 43: 3036-3038.
65. Hollingshead S, Vapnek D (1985) Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase. Plasmid 13: 17-30. (Pubitemid 15169412)
66. Paulander W, Maisnier-Patin S, Andersson DI (2009) The fitness cost of streptomycin resistance depends on rpsL mutation, carbon source and RpoS (sigmaS). Genetics 183: 539-546, 531SI-532SI.
67. Enne VI, Delsol AA, Davis GR, Hayward SL, Roe JM, et al. (2005) Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element. J Antimicrob Chemother 56: 544-551. (Pubitemid 41264134)
68. Tree JJ, Ulett GC, Ong CL, Trott DJ, McEwan AG, et al. (2008) Trade-off between iron uptake and protection against oxidative stress: deletion of cueO promotes uropathogenic Escherichia coli virulence in a mouse model of urinary tract infection. J Bacteriol 190: 6909-6912.
69. Abeyrathne PD, Daniels C, Poon KKH, Matewish MJ, Lam JS (2005) Functional characterization of WaaL, a ligase associated with linking O-antigen polysaccharide to the core of Pseudomonas aeruginosa lipopolysaccharide. J Bacteriol 187: 3002-3012. (Pubitemid 40571592)
70. DeShazer D, Brett PJ, Woods DE (1998) The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol 30: 1081-1100. (Pubitemid 28550130)
71. Bravo D, Silva C, Carter JA, Hoare A, Alvarez SA, et al. (2008) Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella. J Med Microbiol 57: 938-946.
72. Pluschke G, Mayden J, Achtman M, Levine RP (1983) Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Infect Immun 42: 907-913. (Pubitemid 14244355)
73. Hughes C, Phillips R, Roberts AP (1982) Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants. Infect Immun 35: 270-275. (Pubitemid 12200905)
74. Cryz SJ, Jr., Cross AS, Sadoff JC, Furer E (1990) Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines. Infect Immun 58: 373-377. (Pubitemid 20058810)
75. Bortolussi R, Ferrieri P, Bjorksten B, Quie PG (1979) Capsular K1-Polysaccharide of Escherichia-Coli - Relationship to Virulence in Newborn Rats and Resistance to Phagocytosis. Infect Immun 25: 293-298. (Pubitemid 9226041)
76. McCabe WR, Kaijser B, Olling S, Uwaydah M, Hanson LA (1978) Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis 138: 33-41. (Pubitemid 8399825)
77. Taylor PW (1976) Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections. J Med Microbiol 9: 405-421.
78. Gadeberg OV, Mansa B (1990) In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Inhibition by alpha-hemolysin antibody. Zentralbl Bakteriol 273: 492-500. (Pubitemid 20367355)
79. Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC (2002) A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol 169: 6352-6360. (Pubitemid 36903483)
80. Liu YF, Yan JJ, Lei HY, Teng CH, Wang MC, et al. (2012) Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity. Infect Immun 80: 1815-1822.
81. Montenegro MA, Bitter-Suermann D, Timmis JK, Aguero ME, Cabello FC, et al. (1985) traT gene sequences, serum resistance and pathogenicity-related factors in clinical isolates of Escherichia coli and other gram-negative bacteria. J Gen Microbiol 131: 1511-1521. (Pubitemid 15013655)
82. Binns MM, Mayden J, Levine RP (1982) Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV, I-K94. Infect Immun 35: 654-659. (Pubitemid 12164766)
83. Browning DF, Wells TJ, Franca FL, Morris FC, Sevastsyanovich YR, et al. (2013) Laboratory adapted Escherichia coli K-12 becomes a pathogen of Caenorhabditis elegans upon restoration of O antigen biosynthesis. Mol Microbiol 87: 939-950.
84. Schembri MA, Dalsgaard D, Klemm P (2004) Capsule shields the function of short bacterial adhesins. J Bacteriol 186: 1249-1257. (Pubitemid 38248713)
85. Schembri MA, Blom J, Krogfelt KA, Klemm P (2005) Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun 73: 4626-4633. (Pubitemid 41105618)
86. Schneider G, Dobrindt U, Bruggemann H, Nagy G, Janke B, et al. (2004) The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536. Infect Immun 72: 5993-6001. (Pubitemid 39303714)
87. Russo TA, Brown JJ, Jodush ST, Johnson JR (1996) The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli. Infect Immun 64: 2343-2348. (Pubitemid 26165699)
88. Bertani G (1951) Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62: 293-300.
89. Orskov F, Orskov I (1984) Serotyping of Escherichia coli. In: Bergan T, editor. Methods in Microbiology: Academic Press. pp. 43-112.
90. West NP, Jungnitz H, Fitter JT, McArthur JD, Guzman CA, et al. (2000) Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect Immun 68: 4673-4680. (Pubitemid 30497740)
91. Lesse AJ, Campagnari AA, Bittner WE, Apicella MA (1990) Increased Resolution of Lipopolysaccharides and Lipooligosaccharides Utilizing Tricine-Sodium Dodecyl Sulfate-Polyacrylamide Gel-Electrophoresis. Journal of Immunological Methods 126: 109-117. (Pubitemid 20041434)
92. Tsai CM, Frasch CE (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115-119. (Pubitemid 12142846)
93. Roos V, Schembri MA, Ulett GC, Klemm P (2006) Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 152: 1799-1806.
94. Bachmann BJ (1972) Pedigrees of some mutant strains of Escherichia coli K-12. Bacteriol Rev 36: 525-557.
95. Casadaban MJ, Cohen SN (1980) Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol 138: 179-207. (Pubitemid 10044378)
96. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, et al. (1990) Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58: 1281-1289. (Pubitemid 20151789)
97. Svanborg Eden C, Gotschlich EC, Korhonen TK, Leffler H, Schoolnik G (1983) Aspects on structure and function of pili on uropathogenic Escherichia coli. Prog Allergy 33: 189-202.
98. Silver RP, Aaronson W, Sutton A, Schneerson R (1980) Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. Infect Immun 29: 200-206. (Pubitemid 10085996)